André Soares

LBA1 A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3

Silke Gillessen, Ananya Choudhury, F. Saad et al. · Annals of Oncology · 2024 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

Locally advanced hypopharyngeal squamous cell carcinoma: single-institution outcomes in a cohort of patients curatively treated either with or without larynx preservation

Isabel Reis, Artur Aguiar, Cristiana Alzamora et al. · Radiologia Brasileira · 2016 · 19 citations · Full text

Medicine, Oncology, Otolaryngology +14